NASDAQ: ACAD - ACADIA Pharmaceuticals Inc.

Yield per half year: +0.2685%
Dividend yield: 0.00%
Sector: Healthcare

Share chart ACADIA Pharmaceuticals Inc.

Extended chart Simple chart
Financial Markets by TradingView

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc., биофармацевтическая компания, специализируется на разработке и коммерциализации низкомолекулярных препаратов, предназначенных для удовлетворения неудовлетворенных медицинских потребностей при заболеваниях центральной нервной системы.

more details
Компания предлагает НУПЛАЗИД (пимавансерин) для лечения галлюцинаций и бреда, связанных с психозом при болезни Паркинсона; Трофинетид, новый синтетический аналог для лечения синдрома Ретта; ACP-044, новый первый в своем классе неопиоидный анальгетик для перорального приема для лечения острой и хронической боли; и ACP-319, положительный аллостерический модулятор мускаринового рецептора для лечения когнитивных функций и шизофрении. Он также разрабатывает пимавансерин для лечения психоза, связанного с деменцией, и в качестве дополнительного лечения шизофрении; и пимавансерин в качестве дополнительного лечения большого депрессивного расстройства. ACADIA Pharmaceuticals Inc. была основана в 1993 году, ее штаб-квартира находится в Сан-Диего, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2004-05-27
ISIN US0042251084
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.acadia-pharm.com
Цена ао 17.26
Change price per day: -2.15% (19.08)
Change price per week: +6.26% (17.57)
Change price per month: +9.37% (17.07)
Change price per 3 month: +30.2% (14.34)
Change price per half year: +0.2685% (18.62)
Change price per year: -30.7% (26.94)
Change price per 3 year: -21.52% (23.79)
Change price per 5 year: -64.32% (52.32)
Change price per 10 year: -51.96% (38.86)
Change price per year to date: +14.54% (16.3)
All parameters

Underestimation

Title Value Grade
P/S 7.08 1
P/BV 11.91 1
P/E 0 0
EV/EBITDA -73.9 0
Total: 1.75

Efficiency

Title Value Grade
ROA, % -8.18 0
ROE, % -14.19 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.8434 10
Total: 9.4

Growth impulse

Title Value Grade
Yield Revenue, % 114.29 10
Yield Ebitda, % -69.23 0
Yield EPS, % -76.62 0
Total: 2
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
19.11.2024 19.11.2024 Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER		 Sale 16.81 172 454 10259 0 -0.01 link
19.11.2024 19.11.2024 Kihara James
PRINCIPAL ACCOUNTING OFFICER		 Sale 16.81 68 467 4073 0 0 link
19.11.2024 19.11.2024 Teehan Brendan
EVP, COO, HEAD OF COMMERCIAL		 Sale 16.81 173 630 10329 0 -0.01 link
26.02.2024 27.02.2024 DAVIS STEPHEN
CEO		 Sale 24.67 137 585 5577 0 0 link
26.02.2024 27.02.2024 Kihara James
PRINCIPAL ACCOUNTING OFFICER		 Sale 24.67 11 694 474 0 0 link
26.02.2024 27.02.2024 Teehan Brendan
EVP, COO, HEAD OF COMMERCIAL		 Sale 24.67 15 394 624 0 0 link
26.02.2024 27.02.2024 Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER		 Sale 24.67 19 045 772 0 0 link
08.01.2024 09.01.2024 KIM AUSTIN D.
EVP,General Counsel, Secretary		 Sale 29.96 17 676 590 0 0 link
08.01.2024 09.01.2024 Teehan Brendan
EVP, COO, Head of Commercial		 Sale 29.96 21 901 731 0 0 link
08.01.2024 09.01.2024 DAVIS STEPHEN
CEO		 Sale 29.96 111 811 3732 0 0 link
21.08.2023 23.08.2023 Schneyer Mark C.
EVP, Chief Financial Officer		 Sale 29 290 000 10000 0 -0.01 link
12.07.2023 13.07.2023 DAVIS STEPHEN
CEO		 Sale 25.05 1 380 360 55104 0 -0.03 link
11.07.2023 13.07.2023 DAVIS STEPHEN
CEO		 Sale 25 412 450 16498 0 -0.01 link
01.05.2023 02.05.2023 DAVIS STEPHEN
CEO		 Sale 21.18 165 331 7806 0 0 link
01.05.2023 02.05.2023 Teehan Brendan
EVP, COO, Head of Commercial		 Sale 21.18 11 607 548 0 0 link
01.05.2023 02.05.2023 KIM AUSTIN D.
EVP,General Counsel, Secretary		 Sale 21.18 19 422 917 0 0 link
29.04.2023 02.05.2023 DAVIS STEPHEN
CEO		 Purchase 21.38 334 063 15625 0 0.01 link
29.04.2023 02.05.2023 Teehan Brendan
EVP, COO, Head of Commercial		 Purchase 21.38 33 502 1567 0 0 link
06.04.2023 07.04.2023 KIM AUSTIN D.
EVP,General Counsel, Secretary		 Sale 18.16 26 441 1456 0 0 link
06.04.2023 07.04.2023 DAVIS STEPHEN
CEO		 Sale 18.16 155 849 8582 0 -0.01 link
06.04.2023 07.04.2023 Schneyer Mark C.
EVP, Chief Financial Officer		 Sale 18.16 34 795 1916 0 0 link
06.04.2023 07.04.2023 Kihara James
Principal Accounting Officer		 Sale 18.16 12 730 701 0 0 link
06.04.2023 07.04.2023 Teehan Brendan
EVP, COO, Head of Commercial		 Sale 18.16 31 798 1751 0 0 link
09.06.2022 10.06.2022 Schneyer Mark C.
EVP, Chief Financial Officer		 Sale 17.91 11 695 653 0 0 link
08.06.2022 10.06.2022 Schneyer Mark C.
EVP, Chief Financial Officer		 Purchase 17.09 32 351 1893 0 0 link
08.04.2022 11.04.2022 Kihara James
Principal Accounting Officer		 Sale 27.05 27 726 1025 0 0 link
23.02.2022 25.02.2022 DAVIS STEPHEN
CEO		 Sale 23.8 93 486 3928 0 0 link
23.02.2022 25.02.2022 DAVIS STEPHEN
CEO		 Purchase 25.6 280 247 10945 0 0.01 link
23.02.2022 25.02.2022 KIM AUSTIN D.
EVP & General Counsel		 Sale 23.8 18 612 782 0 0 link
23.02.2022 25.02.2022 KIM AUSTIN D.
EVP & General Counsel		 Purchase 25.6 56 664 2213 0 0 link
23.02.2022 25.02.2022 Teehan Brendan
EVP, COO, Head of Commercial		 Sale 23.8 11 234 472 0 0 link
23.02.2022 25.02.2022 Teehan Brendan
EVP, COO, Head of Commercial		 Purchase 25.6 28 319 1106 0 0 link
06.01.2022 10.01.2022 DAVIS STEPHEN
CEO		 Sale 23.05 85 700 3718 0 0 link
06.01.2022 10.01.2022 Stankovic Srdjan R.
President		 Sale 23.05 44 648 1937 0 0 link
06.01.2022 10.01.2022 KIM AUSTIN D.
EVP & General Counsel		 Sale 23.05 13 231 574 0 0 link
06.01.2022 10.01.2022 Teehan Brendan
EVP, COO, Head of Commercial		 Sale 23.05 12 401 538 0 0 link
22.11.2021 23.11.2021 Stankovic Srdjan R.
President		 Sale 19.01 53 285 2803 0 0 link

Institutions Volume Share, %
Baker Brothers Advisors, LLC 42864612 26.01
Vanguard Group Inc 13396009 8.13
Blackrock Inc. 11410483 6.93
RTW Investments LP 11253551 6.83
State Street Corporation 6465026 3.92
EcoR1 Capital, LLC 5991479 3.64
FMR, LLC 5265358 3.2
Price (T.Rowe) Associates Inc 5178509 3.14
Shaw D.E. & Co., Inc. 3754598 2.28
Fred Alger Management, LLC 3176775 1.93

ETF Share, % Profitability for 1 year, % Dividends, %
PSYK ETF 4.28 0
iShares Neuroscience and Healthcare ETF 3.89274 19.72 0.03
First Trust NYSE Arca Biotechnology Index Fund 2.89222 16.92 0.26101
Invesco Biotechnology & Genome ETF 2.8716 26.49 0.16298
Virtus LifeSci Biotech Products ETF 1.57661 36.79 0.13953
ProShares UltraShort Nasdaq Biotechnology 0.81 -40.36 1.76
Direxion Daily S&P Biotech Bull 3x Shares 0.4198 4067.92 0.25924
First Trust Nasdaq Pharmaceuticals ETF 0.33232 18.37 2.19901
Principal U.S. Small-Cap ETF 0.29038 16.7 1.20466
Future Tech ETF 0.26494 426.34 0.8416
Principal Healthcare Innovators ETF 0.26494 618.5 0.8416
Franklin U.S. Small Cap Multifactor Index ETF 0.26419 14.43 1.90721
Invesco Nasdaq Biotechnology ETF 0.26129 28.58 0.8565
Global X Aging Population ETF 0.252 20.37 1.46713
WisdomTree Europe SmallCap Dividend Fund 0.22927 -96.01 4.99948
Donoghue Forlines Innovation ETF 0.20684 28.12 0.89556
ProShares Ultra Nasdaq Biotechnology 0.17925 51.7 0.85651
Vanguard Russell 2000 Growth ETF 0.15 23.05 0.60264
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.14645 31.36 1.41955
iShares Russell 2000 Growth ETF 0.146 38.04 0.6026
BNY Mellon US Small Cap Core Equity ETF 0.13668 30.07 1.75333
iShares Morningstar Small-Cap Growth ETF 0.08563 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.08563 587.89 0.72598
WisdomTree International SmallCap Dividend Fund 0.08377 8.52 5.22973
Dimensional International Small Cap Value ETF 0.07661 7.13 4.55441
Vanguard Russell 2000 ETF 0.07 17.16 1.48801
WisdomTree Dynamic Currency Hedged International SmallCap Equity Fund 0.06535 7.55 5.2239
Avantis International Small Cap Value ETF 0.06518 14.36 4.23496
SPDR S&P International Small Cap ETF 0.05276 8.94 3.10348
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.05267 21.79 1.42082
Schwab U.S. Small-Cap ETF 0.05205 17.47 1.51433
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.05076 18.2 1.66828
iShares Morningstar Small-Cap ETF 0.04331 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.04331 391.25 1.60498
ProShares UltraPro Russell2000 0.04273 89.82 1.47873
Dimensional International Small Cap ETF 0.0316 5.69 3.34747
Fidelity MSCI Health Care Index ETF 0.02584 3 1.46057
SPDR SSGA US Small Cap Low Volatility Index ETF 0.02163 34.33 2.97092
Vanguard U.S. Quality Factor ETF 0.02 15.59 1.62247
Humankind US Stock ETF 0.01867 18.81 1.99919
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01436 17.58 1.75869
Schwab Fundamental International Small Co. Index ETF 0.01248 8.31 3.46652
ProShares Hedge Replication ETF 0.01195 5.92 1.47892
Dimensional International Core Equity 2 ETF 0.0118 6.52 3.69996
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00618 21.94 1.69572
Dimensional World ex U.S. Core Equity 2 ETF 0.00603 13.06 3.62488
Avantis International Equity ETF 0.00538 6.46 3.80856
Dimensional International Core Equity Market ETF 0.00435 13.09 3.48343
SPDR Portfolio Europe ETF 0.00412 8.94 3.66537
iShares Russell 3000 ETF 0.00387 24.83 1.43482
Schwab 1000 Index ETF 0.00364 25.15 1.42441
Schwab U.S. Broad Market ETF 0.00352 24.86 1.43354
Dimensional US Core Equity Market ETF 0.00234 30.98 1.40618
Dimensional U.S. Equity ETF 0.0015 31.53 1.3557
Dimensional U.S. Core Equity 2 ETF 0.00138 30.76 1.47098
Avantis Responsible International Equity ETF 0.00091 17.44 3.61591
Vanguard ESG U.S. Stock ETF 0 23.54 1.26927
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Mr. James K. Kihara VP, Chief Accounting Officer & Corporate Controller N/A 1981 (44 years)
Mr. Stephen R. Davis J.D. President, CEO & Director 1.46M 1961 (64 years)
Mr. Mark C. Schneyer Executive VP & CFO 701.03k 1974 (51 year)
Mr. Brendan P. Teehan Executive VP, COO & Head of Commercial 724.31k 1969 (56 years)
Mr. Rob Ackles Senior VP & Chief People Officer N/A
Ms. Holly Valdiviez Senior VP & Head of Sales N/A
Mr. Albert S. Kildani Senior Vice President of Investor Relations & Corporate Communications N/A
Mr. Benir Ruano Senior Vice President of Technical Development & Operations N/A
Ms. Jennifer J. Rhodes J.D. Executive VP, Chief Legal Officer & Secretary N/A 1970 (55 years)
Dr. Elizabeth H.Z. Thompson Ph.D. Executive VP and Head of Research & Development 1975 (50 years)

Address: United States, San Diego, CA , 12830 El Camino Real - open in Google maps, open in Yandex maps
Website: https://www.acadia-pharm.com